Neuroleptic malignant syndrome is the rarest of the neuroleptic induced movement disorders. It is the most serious and represents a neurologic emergency in most cases. It has now been reported to occur with all drugs that effect the central dopaminergic system (including dopamine agonists and levodopa). There's an isolated report of neuroleptic malignant syndrome in a patient on a trycyclic medication. It is likely an idiosyncratic reaction and patients can, if needed, be given the same agent again without recurrence.
It is estimated that 0.5-1% of patients exposed to neuroleptics will develop this syndrome. Most patients will develop it shortly after initial exposure and 90% within two weeks of starting the neuroleptic. It can occur with all the neuroleptics but haldol and trifluperazine are the most common. It has also been seen with clozapine and metoclopramide.
The classic triad involves the autonomic nervous system (fever in 100%), the extrapyramidal system (rigidity), and cognitive changes. The two characteristic laboratory findings reported in 75% of cases are a high CPK and leukocytosis. 95% of patients are iron deficient. The CSF is usually normal. The EEG can show diffuse slowing. Other features include tachypnea (78%), diaphoresis (60%), and labile blood pressure (54%). The temperature does not usually exceed 41
Sponsored Links
Call to Speak to a Specialist
Call 1-877-398-2002 Anytime To Discuss Treatment Options if you or a loved one is struggling with mental health issues.
Find a Treatment Center
To search by State and City instead of by Zip Code / Postal Code, select a state from the list below.
For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.
Burnout syndrome is both a street and psychological term bandied about a lot lately to describe people dissatisfied with their work and life. Especially in a bad economy wher…
It’s always a challenge to find the right antidepressant or combination of antidepressants for a patient. Given the weeks it takes to see improvement, valuable time can be …
As per a study recently presented by researchers at the American Psychiatric Association, Latinos as a group appear more likely to develop both diabetes and a mood disorder --…
Risperidone is an atypical antispsychotic drug -- originally developed by Janssen-Cilag and released in 1994 -- that is sold under the brand name Risperdal.
Generally, the drug is utilized in tr…
Elevated levels of cortisol can be extremely damaging to one’s health. Luckily, a number of examinations are available to detect, and ultimately, treat this situation.
The most common way of m…
Quetiapine is the generic name for a prescription, oral, antipsychotic drug approved for treating schizophrenia, bipolar disorder and related depression or major depressive disorder. It is sometimes …
The information provided on the PsyWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of PsyWeb.com nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
Sponsored Links
SupportGroups.com
SupportGroups.com provides a support network for those dealing with mental health and other life's challenges. Click on the following links to get the support in a confidential, caring environment.